Overheard at HIDC: Lawyers can bite even if FDA doesn’t

Briefs, CBD Products & CBD Business News, FDA, Hemp Industry News for Hemp & CBD Retailers, Hemp Legalization & Regulatory News for Hemp Businesses, Saul Ewing Arnstein & Lehr

CBD manufacturers in the U.S. have more to worry about than confusing regulations about how the extract can be legally made and sold.

They’ve also got to keep an eye on the court dockets. That’s because plaintiffs’ attorneys are stepping in to challenge CBD companies in an absence of clear rules, according to Jonathan Havens,  head of the cannabis practice group at the Saul Ewing Arnstein & Lehr law firm in Baltimore and Washington DC.

Havens told entrepreneurs at the Hemp Industry Daily Conference Direct that enterprising attorneys who file claims can drive a nascent industry when government is slow to chart rules, as in the current landscape for CBD.

Havens warned CBD makers to be especially vigilant about labeling accuracy and making medical claims, which can prompt a warning from the U.S. Food and Drug Administration for unscrupulous companies.

“When you get a warning letter, it can mean a claims letter from a plaintiffs’ attorney shortly thereafter,” he said.

His tips for avoiding FDA letters included not mentioning a product to treat:

  • Pain and inflammation.
  • Psychosis and schizophrenia.
  • Breast and colon cancer.
  • Diabetes.
  • Opioid addiction.
  • Fibromyalgia.
  • Crohn’s disease.

To get more insights about the current legal landscape for hemp operators, click here.

Articles You May Like

When You Use CBD Every Day, This Is What Happens To Your Body
Legal Weed Might Disappear Thanks to Joe Biden | Let Lee Explain
Budko News: CBD Facts
My First Time Smoking CBD | Hightop Dreadlocks | #dreadlockjourmey #tplocks #CBD
Myths and Facts about CBD

Leave a Reply

Your email address will not be published. Required fields are marked *